AI as a Medical Device

Written By

sophie vo Module
Sophie Vo

Associate
UK

I am a Senior Associate in the Intellectual Property Group in London with a particular focus on the life sciences and healthcare sectors.

Last month, the Medicines & Healthcare products Regulatory Agency (“MHRA“) published guidance on “Software and Artificial Intelligence (AI) as a Medical Device”. It didn’t necessarily provide for any new regulatory approach to AI in the therapeutic space, but it brought together some important material during this period of increasing interest in AI to effectively remind software providers of their compliance obligations in the life sciences and healthcare space.

Latest insights

More Insights
featured image

ACMA Cracks Down on Non-Compliance with National Self-Exclusion Register Requirements

5 minutes Jun 04 2025

Read More
Curiosity line teal background

Latest developments in EU and German defence procurement: Defence procurement panel overview and key takeaways

5 minutes Jun 04 2025

Read More
Curiosity line pink background

Latest developments in UK and NATO DIANA defence procurement: Defence procurement panel overview and key takeaways

7 minutes Jun 04 2025

Read More